GlassScriptPhysician profile
Amanda K Goldsmith
NPI 1336634294
$471.76
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.53 · 2022: $264 · 2023: $153 · 2024: $38.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $110.83 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $220.28 | 2022-2023 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $52.50 | 2022-2023 | Breztri |
| Janssen Pharmaceuticals, INC | $48.81 | 2022 | |
| Grifols USA, LLC | $38.06 | 2024 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $34.83 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.98 | 2022 | |
| Jazz Pharmaceuticals INC. | $21.67 | 2022 | |
| Abbvie INC. | $17.10 | 2023 | |
| Mylan Specialty L.P. | $16.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Goldsmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.